Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1994 Feb 15;91(4):1579–1583. doi: 10.1073/pnas.91.4.1579

Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B.

K M Carlson 1, S Dou 1, D Chi 1, N Scavarda 1, K Toshima 1, C E Jackson 1, S A Wells Jr 1, P J Goodfellow 1, H Donis-Keller 1
PMCID: PMC43203  PMID: 7906417

Abstract

Multiple endocrine neoplasia type 2B (MEN 2B) is a human cancer syndrome characterized by medullary thyroid carcinoma (MTC), pheochromocytomas, mucosal neuromas, ganglioneuromas of the intestinal tract, and skeletal and ophthalmic abnormalities. It appears both as an inherited disorder and as de novo disease. Sequence analysis of germ-line DNA from MEN 2B patients revealed the existence of the same point mutation in the RET protooncogene in 34 unrelated individuals. This sequence difference was not observed in 93 unaffected individuals, including the normal parents of 14 de novo MEN 2B patients. The mutation (ATG-->ACG) results in the replacement of methionine with threonine within the catalytic core region of the tyrosine kinase domain. We propose that this amino acid replacement effects substrate interactions and results in dominant oncogenic activity by the RET protein. Missense mutations in the extracellular ligand-binding domain of the RET protooncogene previously have been associated with two other disorders [MEN 2A and familial MTC (FMTC)] in which MTC is observed. MEN 2B represents the third form of heritable MTC known to be an allele of RET. Alterations in two different functional domains of the putative receptor protein tyrosine kinase are implicated in development of MTC.

Full text

PDF
1579

Images in this article

1580Image
on p.1580

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Angrist M., Kauffman E., Slaugenhaupt S. A., Matise T. C., Puffenberger E. G., Washington S. S., Lipson A., Cass D. T., Reyna T., Weeks D. E. A gene for Hirschsprung disease (megacolon) in the pericentromeric region of human chromosome 10. Nat Genet. 1993 Aug;4(4):351–356. doi: 10.1038/ng0893-351. [DOI] [PubMed] [Google Scholar]
  2. Bryant D. L., Parsons J. T. Amino acid alterations within a highly conserved region of the Rous sarcoma virus src gene product pp60src inactivate tyrosine protein kinase activity. Mol Cell Biol. 1984 May;4(5):862–866. doi: 10.1128/mcb.4.5.862. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bryant D., Parsons J. T. Site-directed point mutation in the src gene oF rous sarcoma virus results in an inactive src gene product. J Virol. 1983 Mar;45(3):1211–1216. doi: 10.1128/jvi.45.3.1211-1216.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cadena D. L., Gill G. N. Receptor tyrosine kinases. FASEB J. 1992 Mar;6(6):2332–2337. doi: 10.1096/fasebj.6.6.1312047. [DOI] [PubMed] [Google Scholar]
  5. Cooper J. A., Howell B. The when and how of Src regulation. Cell. 1993 Jun 18;73(6):1051–1054. doi: 10.1016/0092-8674(93)90634-3. [DOI] [PubMed] [Google Scholar]
  6. Donis-Keller H., Dou S., Chi D., Carlson K. M., Toshima K., Lairmore T. C., Howe J. R., Moley J. F., Goodfellow P., Wells S. A., Jr Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet. 1993 Jul;2(7):851–856. doi: 10.1093/hmg/2.7.851. [DOI] [PubMed] [Google Scholar]
  7. Farndon J. R., Leight G. S., Dilley W. G., Baylin S. B., Smallridge R. C., Harrison T. S., Wells S. A., Jr Familial medullary thyroid carcinoma without associated endocrinopathies: a distinct clinical entity. Br J Surg. 1986 Apr;73(4):278–281. doi: 10.1002/bjs.1800730411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Grieco M., Santoro M., Berlingieri M. T., Melillo R. M., Donghi R., Bongarzone I., Pierotti M. A., Della Porta G., Fusco A., Vecchio G. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell. 1990 Feb 23;60(4):557–563. doi: 10.1016/0092-8674(90)90659-3. [DOI] [PubMed] [Google Scholar]
  9. Hanks S. K., Quinn A. M., Hunter T. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science. 1988 Jul 1;241(4861):42–52. doi: 10.1126/science.3291115. [DOI] [PubMed] [Google Scholar]
  10. Howe J. R., Lairmore T. C., Mishra S. K., Dou S., Veile R., Wells S. A., Jr, Donis-Keller H. Improved predictive test for MEN2, using flanking dinucleotide repeats and RFLPs. Am J Hum Genet. 1992 Dec;51(6):1430–1442. [PMC free article] [PubMed] [Google Scholar]
  11. Ishizaka Y., Ushijima T., Sugimura T., Nagao M. cDNA cloning and characterization of ret activated in a human papillary thyroid carcinoma cell line. Biochem Biophys Res Commun. 1990 Apr 30;168(2):402–408. doi: 10.1016/0006-291x(90)92335-w. [DOI] [PubMed] [Google Scholar]
  12. Iwamoto T., Takahashi M., Ito M., Hamatani K., Ohbayashi M., Wajjwalku W., Isobe K., Nakashima I. Aberrant melanogenesis and melanocytic tumour development in transgenic mice that carry a metallothionein/ret fusion gene. EMBO J. 1991 Nov;10(11):3167–3175. doi: 10.1002/j.1460-2075.1991.tb04878.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Iwamoto T., Taniguchi M., Asai N., Ohkusu K., Nakashima I., Takahashi M. cDNA cloning of mouse ret proto-oncogene and its sequence similarity to the cadherin superfamily. Oncogene. 1993 Apr;8(4):1087–1091. [PubMed] [Google Scholar]
  14. Iwamoto T., Taniguchi M., Wajjwalku W., Nakashima I., Takahashi M. Neuroblastoma in a transgenic mouse carrying a metallothionein/ret fusion gene. Br J Cancer. 1993 Mar;67(3):504–507. doi: 10.1038/bjc.1993.94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Knighton D. R., Cadena D. L., Zheng J., Ten Eyck L. F., Taylor S. S., Sowadski J. M., Gill G. N. Structural features that specify tyrosine kinase activity deduced from homology modeling of the epidermal growth factor receptor. Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5001–5005. doi: 10.1073/pnas.90.11.5001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Knighton D. R., Zheng J. H., Ten Eyck L. F., Ashford V. A., Xuong N. H., Taylor S. S., Sowadski J. M. Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science. 1991 Jul 26;253(5018):407–414. doi: 10.1126/science.1862342. [DOI] [PubMed] [Google Scholar]
  17. Knighton D. R., Zheng J. H., Ten Eyck L. F., Xuong N. H., Taylor S. S., Sowadski J. M. Structure of a peptide inhibitor bound to the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science. 1991 Jul 26;253(5018):414–420. doi: 10.1126/science.1862343. [DOI] [PubMed] [Google Scholar]
  18. Kuma K., Iwabe N., Miyata T. Motifs of cadherin- and fibronectin type III-related sequences and evolution of the receptor-type-protein tyrosine kinases: sequence similarity between proto-oncogene ret and cadherin family. Mol Biol Evol. 1993 May;10(3):539–551. doi: 10.1093/oxfordjournals.molbev.a040033. [DOI] [PubMed] [Google Scholar]
  19. Lairmore T. C., Howe J. R., Korte J. A., Dilley W. G., Aine L., Aine E., Wells S. A., Jr, Donis-Keller H. Familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2B map to the same region of chromosome 10 as multiple endocrine neoplasia type 2A. Genomics. 1991 Jan;9(1):181–192. doi: 10.1016/0888-7543(91)90237-9. [DOI] [PubMed] [Google Scholar]
  20. Lax I., Bellot F., Howk R., Ullrich A., Givol D., Schlessinger J. Functional analysis of the ligand binding site of EGF-receptor utilizing chimeric chicken/human receptor molecules. EMBO J. 1989 Feb;8(2):421–427. doi: 10.1002/j.1460-2075.1989.tb03393.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lax I., Burgess W. H., Bellot F., Ullrich A., Schlessinger J., Givol D. Localization of a major receptor-binding domain for epidermal growth factor by affinity labeling. Mol Cell Biol. 1988 Apr;8(4):1831–1834. doi: 10.1128/mcb.8.4.1831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lyonnet S., Bolino A., Pelet A., Abel L., Nihoul-Fékété C., Briard M. L., Mok-Siu V., Kaariainen H., Martucciello G., Lerone M. A gene for Hirschsprung disease maps to the proximal long arm of chromosome 10. Nat Genet. 1993 Aug;4(4):346–350. doi: 10.1038/ng0893-346. [DOI] [PubMed] [Google Scholar]
  23. Mathew C. G., Chin K. S., Easton D. F., Thorpe K., Carter C., Liou G. I., Fong S. L., Bridges C. D., Haak H., Kruseman A. C. A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10. Nature. 1987 Aug 6;328(6130):527–528. doi: 10.1038/328527a0. [DOI] [PubMed] [Google Scholar]
  24. Miya A., Yamamoto M., Morimoto H., Tanaka N., Shin E., Karakawa K., Toyoshima K., Ishizaka Y., Mori T., Takai S. Expression of the ret proto-oncogene in human medullary thyroid carcinomas and pheochromocytomas of MEN 2A. Henry Ford Hosp Med J. 1992;40(3-4):215–219. [PubMed] [Google Scholar]
  25. Moley J. F., Brother M. B., Fong C. T., White P. S., Baylin S. B., Nelkin B., Wells S. A., Brodeur G. M. Consistent association of 1p loss of heterozygosity with pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes. Cancer Res. 1992 Feb 15;52(4):770–774. [PubMed] [Google Scholar]
  26. Moller D. E., Yokota A., White M. F., Pazianos A. G., Flier J. S. A naturally occurring mutation of insulin receptor alanine 1134 impairs tyrosine kinase function and is associated with dominantly inherited insulin resistance. J Biol Chem. 1990 Sep 5;265(25):14979–14985. [PubMed] [Google Scholar]
  27. Mulligan L. M., Kwok J. B., Healey C. S., Elsdon M. J., Eng C., Gardner E., Love D. R., Mole S. E., Moore J. K., Papi L. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature. 1993 Jun 3;363(6428):458–460. doi: 10.1038/363458a0. [DOI] [PubMed] [Google Scholar]
  28. Nagao M., Ishizaka Y., Nakagawara A., Kohno K., Kuwano M., Tahira T., Itoh F., Ikeda I., Sugimura T. Expression of ret proto-oncogene in human neuroblastomas. Jpn J Cancer Res. 1990 Apr;81(4):309–312. doi: 10.1111/j.1349-7006.1990.tb02566.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Norton J. A., Froome L. C., Farrell R. E., Wells S. A., Jr Multiple endocrine neoplasia type IIb: the most aggressive form of medullary thyroid carcinoma. Surg Clin North Am. 1979 Feb;59(1):109–118. doi: 10.1016/s0039-6109(16)41737-8. [DOI] [PubMed] [Google Scholar]
  30. Norum R. A., Lafreniere R. G., O'Neal L. W., Nikolai T. F., Delaney J. P., Sisson J. C., Sobol H., Lenoir G. M., Ponder B. A., Willard H. F. Linkage of the multiple endocrine neoplasia type 2B gene (MEN2B) to chromosome 10 markers linked to MEN2A. Genomics. 1990 Oct;8(2):313–317. doi: 10.1016/0888-7543(90)90287-5. [DOI] [PubMed] [Google Scholar]
  31. Orkin S. H., Kazazian H. H., Jr The mutation and polymorphism of the human beta-globin gene and its surrounding DNA. Annu Rev Genet. 1984;18:131–171. doi: 10.1146/annurev.ge.18.120184.001023. [DOI] [PubMed] [Google Scholar]
  32. Pierotti M. A., Santoro M., Jenkins R. B., Sozzi G., Bongarzone I., Grieco M., Monzini N., Miozzo M., Herrmann M. A., Fusco A. Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/PTC. Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1616–1620. doi: 10.1073/pnas.89.5.1616. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Santoro M., Rosati R., Grieco M., Berlingieri M. T., D'Amato G. L., de Franciscis V., Fusco A. The ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas. Oncogene. 1990 Oct;5(10):1595–1598. [PubMed] [Google Scholar]
  34. Schlessinger J., Ullrich A. Growth factor signaling by receptor tyrosine kinases. Neuron. 1992 Sep;9(3):383–391. doi: 10.1016/0896-6273(92)90177-f. [DOI] [PubMed] [Google Scholar]
  35. Sheffield V. C., Beck J. S., Kwitek A. E., Sandstrom D. W., Stone E. M. The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions. Genomics. 1993 May;16(2):325–332. doi: 10.1006/geno.1993.1193. [DOI] [PubMed] [Google Scholar]
  36. Simpson N. E., Kidd K. K., Goodfellow P. J., McDermid H., Myers S., Kidd J. R., Jackson C. E., Duncan A. M., Farrer L. A., Brasch K. Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage. Nature. 1987 Aug 6;328(6130):528–530. doi: 10.1038/328528a0. [DOI] [PubMed] [Google Scholar]
  37. Spector B., Klintworth G. K., Wells S. A., Jr Histologic study of the ocular lesions in multiple endocrine neoplasia syndrome type IIb. Am J Ophthalmol. 1981 Feb;91(2):204–215. doi: 10.1016/0002-9394(81)90175-6. [DOI] [PubMed] [Google Scholar]
  38. Spritz R. A., Giebel L. B., Holmes S. A. Dominant negative and loss of function mutations of the c-kit (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism. Am J Hum Genet. 1992 Feb;50(2):261–269. [PMC free article] [PubMed] [Google Scholar]
  39. Srivastava A. K., Montanaro V., Kere J. Simplified template preparation and improved direct sequencing using Taq polymerase. PCR Methods Appl. 1992 May;1(4):255–256. doi: 10.1101/gr.1.4.255. [DOI] [PubMed] [Google Scholar]
  40. Tahira T., Ishizaka Y., Itoh F., Nakayasu M., Sugimura T., Nagao M. Expression of the ret proto-oncogene in human neuroblastoma cell lines and its increase during neuronal differentiation induced by retinoic acid. Oncogene. 1991 Dec;6(12):2333–2338. [PubMed] [Google Scholar]
  41. Tahira T., Ishizaka Y., Sugimura T., Nagao M. Expression of proto-ret mRNA in embryonic and adult rat tissues. Biochem Biophys Res Commun. 1988 Jun 30;153(3):1290–1295. doi: 10.1016/s0006-291x(88)81368-8. [DOI] [PubMed] [Google Scholar]
  42. Takahashi M., Buma Y., Hiai H. Isolation of ret proto-oncogene cDNA with an amino-terminal signal sequence. Oncogene. 1989 Jun;4(6):805–806. [PubMed] [Google Scholar]
  43. Takahashi M., Buma Y., Iwamoto T., Inaguma Y., Ikeda H., Hiai H. Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains. Oncogene. 1988 Nov;3(5):571–578. [PubMed] [Google Scholar]
  44. Takahashi M., Cooper G. M. ret transforming gene encodes a fusion protein homologous to tyrosine kinases. Mol Cell Biol. 1987 Apr;7(4):1378–1385. doi: 10.1128/mcb.7.4.1378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Vetrie D., Vorechovský I., Sideras P., Holland J., Davies A., Flinter F., Hammarström L., Kinnon C., Levinsky R., Bobrow M. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature. 1993 Jan 21;361(6409):226–233. doi: 10.1038/361226a0. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES